Abbott will be trying its hand in the growing field of intravascular lithotripsy, with a clinical study to examine an unnamed ...
13h
Zacks Investment Research on MSNABT Stock to Gain From FDA IDE Approval for Its Coronary IVL SystemAbbott ABT has received the FDA’s investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (“IVL”) system to evaluate the treatment of severe calcification in coronary ...
Johnson & Johnson and Boston Scientific have also recently made moves to sell their own coronary intravascular lithotripsy ...
Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...
Abbott (NYSE: ABT) received FDA investigational device exemption (IDE) approval for its coronary intravascular lithotripsy ...
Critics say a new, broader definition of high-risk plaque opens the door to more tests, diagnoses, and invasive procedures, steering us down a potentially harmful path.
Tamim Iqbal has undergone angioplasty after suffering a massive heart attack during Mohammedan Sporting Club’s match against the Shinepukur Cricket Club in the ongoing Dhaka Premier Division Cricket ...
Abbott (NYSE: ABT) today announced that the U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) for its Coronary Intravascular Lithotripsy (IVL) System to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results